Cargando…
Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models
Background. For development of individualized treatment on a routine basis, transfer of patients' tumor tissue in a xenograft model (i.e., generation of patient-derived xenografts (PDX)) is desirable for molecular, biochemical, or functional analyses. Drawbacks are dissatisfactory tumor take ra...
Autores principales: | Gock, Michael, Kühn, Florian, Mullins, Christina Susanne, Krohn, Mathias, Prall, Friedrich, Klar, Ernst, Linnebacher, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141319/ https://www.ncbi.nlm.nih.gov/pubmed/27999790 http://dx.doi.org/10.1155/2016/1715053 |
Ejemplares similares
-
Cryopreservation of human colorectal carcinomas prior to xenografting
por: Linnebacher, Michael, et al.
Publicado: (2010) -
Human Colorectal Carcinoma Infiltrating B Lymphocytes Are Active Secretors of the Immunoglobulin Isotypes A, G, and M
por: Mullins, Christina Susanne, et al.
Publicado: (2019) -
Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment
por: Prall, Friedrich, et al.
Publicado: (2017) -
Establishment, functional and genetic characterization of a colon derived large cell neuroendocrine carcinoma cell line
por: Gock, Michael, et al.
Publicado: (2018) -
Integrated Biobanking and Tumor Model Establishment of Human Colorectal Carcinoma Provides Excellent Tools for Preclinical Research
por: Mullins, Christina S., et al.
Publicado: (2019)